Rivatig™

Rivastigmine
Anti-Alzheimers (CNS Preparations)

Indication:

Mild to moderate dementia caused by Alzheimer’s or Parkinson’s disease.

Dosage & Administration:

Initially, 1.5 mg Capsule twice a day.

Preparation:

Each box contains 20 Capsules in blister pack.